30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Michael Hayden

Track

Insider profile

Currently holds positions in Aurinia Pharmaceuticals Inc, Ionis Pharmaceuticals Inc and Xenon Pharmaceuticals Inc

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 24% 68% 82%
Transactions
9 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Aurinia Pharmaceuticals Inc Feb. 22, 2018 -
Director Ionis Pharmaceuticals Inc Sept. 24, 2018 -
Independent Director Xenon Pharmaceuticals Inc Jan. 1, 1996 -
President - Global Research and Development, Chief Scientific Officer Teva Pharmaceutical Industries Ltd May 8, 2012 - Dec. 31, 2017
Michael Hayden's trades of Ionis Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-05-02 2025-05-01
B Purchase
16,702 -6.7%
331.60
US$1,340,901 		16,702 -6.7% 331.60 US$1,340,901
2024-12-26 2024-12-23
B Purchase
75,673 +23.4%
133.19
US$2,205,916 		75,673 +23.4% 133.19 US$2,205,916
2024-12-26 2024-12-23
B Purchase
2,429 -19.4%
317.49
US$1,629,302 		2,429 -19.4% 317.49 US$1,629,302
2023-09-26 2023-09-22
B Purchase
20,000 +1.5%
4.91
US$98,200 		20,000 +1.5% 4.91 US$98,200
2023-08-09 2023-08-08
B Purchase
30,000 +2.4%
5.90
US$177,000 		30,000 +2.4% 5.90 US$177,000
2023-03-30 2023-03-28
US 89Bio Inc (ETNB)
B Purchase
61,538 +inf%
16.15
US$993,839 		61,538 +inf% 16.15 US$993,839
2023-03-30 2022-04-25
US 89Bio Inc (ETNB)
B Purchase
10,000 +10.6%
2.67
US$26,700 		10,000 +10.6% 2.67 US$26,700
2023-03-30 2022-04-07
US 89Bio Inc (ETNB)
B Purchase
10,000 +11.9%
3.48
US$34,750 		10,000 +11.9% 3.48 US$34,750
2023-03-30 2022-03-30
US 89Bio Inc (ETNB)
B Purchase
6,250 +8.0%
3.62
US$22,625 		6,250 +8.0% 3.62 US$22,625
2021-06-22 2021-06-22
S Sale
100,000 -9.1%
25.50
US$2,550,000 		100,000 -9.1% 25.50 US$2,550,000
2020-12-17 2020-12-15
B Purchase
73,665 +165.2%
20.00
US$1,473,300 		73,665 +165.2% 20.00 US$1,473,300